‘Guinea piggers’ at large in the pharmaceutical industry

By Alexandria Pešić and Claire Videau

- Last updated on GMT

Related tags: Pharmaceutical industry, Clinical trial, Pharmacology

‘Guinea piggers’ at large in the pharmaceutical industry
Kerri Weingard, research director for Accumed, says the growing numbers of patients enrolling in multiple clinical trials are threatening the integrity of the clinical development process.

In an exclusive interview with Outsourcing-Pharma, Weingard said her research shows as many as 12 per cent of trial subjects – or 'guinea piggers' – are dual enrolling in trials and 20 per cent of those are signing up to more than 3 trials every year.

This practice skews trial data and puts both the patient and the prosperity of the innovative pharmaceutical industry at risk, believes Weingard.

To combat clinical trial fraud, she suggests everyone in research must play a part in implementing a verification process to help bust the ‘guinea piggers’ and secure the future validity of data.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Planning Your First-In-Human Trial

Planning Your First-In-Human Trial

Altasciences | 15-Jul-2022 | Technical / White Paper

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug. A successfully conducted FIH trial provides...

Related suppliers

Follow us


View more